vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and RLJ Lodging Trust (RLJ). Click either name above to swap in a different company.

RLJ Lodging Trust is the larger business by last-quarter revenue ($340.0M vs $164.7M, roughly 2.1× PTC THERAPEUTICS, INC.). RLJ Lodging Trust runs the higher net margin — -1.9% vs -82.0%, a 80.1% gap on every dollar of revenue. On growth, RLJ Lodging Trust posted the faster year-over-year revenue change (3.6% vs -22.7%). Over the past eight quarters, RLJ Lodging Trust's revenue compounded faster (-4.1% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

The RLJ Companies is an American asset management firm owned by entrepreneur Robert Louis Johnson. After selling Black Entertainment Television in 2001, Johnson's first company, he created RLJ Companies in Bethesda, Maryland. The company's network includes hotel real estate investment, private equity, financial services, asset management, insurance services, car dealerships, sports and entertainment, and video lottery terminal (VLT) gaming. The company is headquartered in Bethesda and has add...

PTCT vs RLJ — Head-to-Head

Bigger by revenue
RLJ
RLJ
2.1× larger
RLJ
$340.0M
$164.7M
PTCT
Growing faster (revenue YoY)
RLJ
RLJ
+26.3% gap
RLJ
3.6%
-22.7%
PTCT
Higher net margin
RLJ
RLJ
80.1% more per $
RLJ
-1.9%
-82.0%
PTCT
Faster 2-yr revenue CAGR
RLJ
RLJ
Annualised
RLJ
-4.1%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PTCT
PTCT
RLJ
RLJ
Revenue
$164.7M
$340.0M
Net Profit
$-135.0M
$-6.4M
Gross Margin
Operating Margin
-43.3%
8.2%
Net Margin
-82.0%
-1.9%
Revenue YoY
-22.7%
3.6%
Net Profit YoY
-104.8%
EPS (diluted)
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
RLJ
RLJ
Q1 26
$340.0M
Q4 25
$164.7M
$328.6M
Q3 25
$211.0M
$330.0M
Q2 25
$178.9M
$363.1M
Q1 25
$1.2B
$328.1M
Q4 24
$213.2M
$330.0M
Q3 24
$196.8M
$345.7M
Q2 24
$186.7M
$369.3M
Net Profit
PTCT
PTCT
RLJ
RLJ
Q1 26
$-6.4M
Q4 25
$-135.0M
$430.0K
Q3 25
$15.9M
$-3.7M
Q2 25
$-64.8M
$28.5M
Q1 25
$866.6M
$3.4M
Q4 24
$-65.9M
$5.4M
Q3 24
$-106.7M
$20.6M
Q2 24
$-99.2M
$37.1M
Operating Margin
PTCT
PTCT
RLJ
RLJ
Q1 26
8.2%
Q4 25
-43.3%
0.2%
Q3 25
1.4%
-1.0%
Q2 25
-19.5%
8.0%
Q1 25
82.5%
1.1%
Q4 24
-76.2%
1.8%
Q3 24
-27.7%
6.1%
Q2 24
-21.5%
10.2%
Net Margin
PTCT
PTCT
RLJ
RLJ
Q1 26
-1.9%
Q4 25
-82.0%
0.1%
Q3 25
7.5%
-1.1%
Q2 25
-36.3%
7.8%
Q1 25
73.7%
1.0%
Q4 24
-30.9%
1.6%
Q3 24
-54.2%
6.0%
Q2 24
-53.1%
10.0%
EPS (diluted)
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
$-1.63
$-0.05
Q3 25
$0.20
$-0.07
Q2 25
$-0.83
$0.15
Q1 25
$10.04
$-0.02
Q4 24
$-0.85
$-0.01
Q3 24
$-1.39
$0.09
Q2 24
$-1.29
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
RLJ
RLJ
Cash + ST InvestmentsLiquidity on hand
$1.9B
$353.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$2.1B
Total Assets
$2.9B
$4.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
RLJ
RLJ
Q1 26
$353.1M
Q4 25
$1.9B
$410.2M
Q3 25
$1.7B
$374.8M
Q2 25
$2.0B
$373.9M
Q1 25
$2.0B
$347.5M
Q4 24
$1.1B
$409.8M
Q3 24
$1.0B
$385.4M
Q2 24
$1.1B
$371.1M
Total Debt
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
$2.2B
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Stockholders' Equity
PTCT
PTCT
RLJ
RLJ
Q1 26
$2.1B
Q4 25
$-205.3M
$2.2B
Q3 25
$-155.8M
$2.2B
Q2 25
$-206.5M
$2.2B
Q1 25
$-185.8M
$2.2B
Q4 24
$-1.1B
$2.3B
Q3 24
$-1.1B
$2.3B
Q2 24
$-980.2M
$2.3B
Total Assets
PTCT
PTCT
RLJ
RLJ
Q1 26
$4.7B
Q4 25
$2.9B
$4.7B
Q3 25
$2.6B
$4.8B
Q2 25
$2.6B
$4.8B
Q1 25
$2.7B
$4.8B
Q4 24
$1.7B
$4.9B
Q3 24
$1.8B
$4.9B
Q2 24
$1.9B
$4.9B
Debt / Equity
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
1.01×
Q3 25
1.01×
Q2 25
1.00×
Q1 25
0.99×
Q4 24
0.97×
Q3 24
0.96×
Q2 24
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
RLJ
RLJ
Operating Cash FlowLast quarter
$-34.3M
Free Cash FlowOCF − Capex
$-36.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
$-34.3M
$243.8M
Q3 25
$-66.3M
$63.3M
Q2 25
$-58.3M
$101.3M
Q1 25
$870.1M
$16.3M
Q4 24
$-30.0M
$285.4M
Q3 24
$-77.0M
$80.1M
Q2 24
$-71.5M
$113.5M
Free Cash Flow
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
$-36.6M
$117.4M
Q3 25
$-69.7M
$33.6M
Q2 25
$-59.6M
$66.1M
Q1 25
$868.4M
$-30.5M
Q4 24
$-33.8M
$148.9M
Q3 24
$-77.5M
$45.4M
Q2 24
$-78.8M
$74.9M
FCF Margin
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
-22.3%
35.7%
Q3 25
-33.1%
10.2%
Q2 25
-33.3%
18.2%
Q1 25
73.8%
-9.3%
Q4 24
-15.8%
45.1%
Q3 24
-39.4%
13.1%
Q2 24
-42.2%
20.3%
Capex Intensity
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
1.4%
38.5%
Q3 25
1.6%
9.0%
Q2 25
0.7%
9.7%
Q1 25
0.1%
14.3%
Q4 24
1.8%
41.4%
Q3 24
0.3%
10.0%
Q2 24
4.0%
10.4%
Cash Conversion
PTCT
PTCT
RLJ
RLJ
Q1 26
Q4 25
566.97×
Q3 25
-4.17×
Q2 25
3.56×
Q1 25
1.00×
4.85×
Q4 24
53.09×
Q3 24
3.89×
Q2 24
3.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

RLJ
RLJ

Room revenue$275.3M81%
Food and beverage revenue$39.7M12%
Other revenue$25.0M7%

Related Comparisons